Abbott Drug Abuse Test Group - Qualitative Low Concentration Correction Solution Group 1
Taiwan·Risk Class 2·MICROGENICS CORPORATION·Registered Sep 25, 2020 – Sep 25, 2025Expired- Analysis ID
- 0d1cc320d98a363109262a8597915c7f
- Customs Code
- DHA05603368008
- Manufacturer
- MICROGENICS CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product is used on the Alinity c analyzer to calibrate the drug of abuse (DOA) for the detection of amphetamine/methamphetamine and cocaine metabolites in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 Calibrated Products
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Sep 25, 2020
- Expiry Date
- Sep 25, 2025
Access comprehensive regulatory information for Abbott Drug Abuse Test Group - Qualitative Low Concentration Correction Solution Group 1 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0d1cc320d98a363109262a8597915c7f and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.